Drug Discovery World: Are TILs the next big thing in cancer treatment?

Sep 1, 2024

DDW’s Megan Thomas speaks with Dr Chantale Bernatchez, Director of Cell Therapy Process Development at CTMC, about tumour infiltrating lymphocyte (TIL) therapy and what’s on the horizon for this new class of cell therapy.

Article Link: https://www.ddw-online.com/ddw-fall-2024-31591-202409/

The Medicine Maker 2026 Power List

Jul 21, 2026

Celebrating 60 inspirational individuals – across small molecules, biopharma, and cell and gene therapy – who are helping to translate pharma’s...

Overcoming Raw Material Variability Challenges for Autologous Adoptive Cell Therapies

Jul 8, 2026

Patient apheresis heterogeneity from prior systemic therapy, collection settings, anticoagulants, timing, and transport/cryopreservation cannot be...

Do you expect continued movement away from one-stop-shop outsourcing toward deeper modality-specific expertise?

Jun 29, 2026

Read the perspectives of industry experts here: Pharma's Almanac

Back

Drug Discovery World: Are TILs the next big thing in cancer treatment?

Recent News

The Medicine Maker 2026 Power List

Overcoming Raw Material Variability Challenges for Autologous Adoptive Cell Therapies

Do you expect continued movement away from one-stop-shop outsourcing toward deeper modality-specific expertise?

Explore CTMC

Resources + Support

Contact Us